7 Stocks Moving In Thursday’s After-Hours Session
Gainers
Mirati Therapeutics (NASDAQ: MRTX) shares are trading higher after the company announced it received Breakthrough Therapy Designation from the FDA for patients with advanced non-small cell lung cancer harboring the KRAS G12C mutation.